Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

Name: Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes
License: Public Domain

China National Biotec Group Company Limited

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19 pneumonia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325168
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.